Newsfeeds - Spark Newswire

5 minute read

Uncategorized

Stretched to the Max, Shandong Ruyi Loses Control of Lycra

Today, 6:41 AM

Key Takeaways: Three and a half years after spending $2.6 billion to buy 53% of Lycra, Shandong Ruyi has lost control of the fashion brand after creditors seized a majority of the company last week

18 minute read

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

Today, 6:41 AM

On Wednesday, 329 companies hit new 52-week lows.

2 minute read

Looking Into DuPont de Nemours’s Recent Short Interest

By Benzinga Insights

Today, 6:41 AM

DuPont de Nemours's (NYSE:DD) short percent of float has risen 5.0% since its last report. The company recently reported that it has 6.40 million shares sold short, which is 1.26% of all regular shares that are available for trading.

2 minute read

How Is The Market Feeling About DuPont de Nemours?

By Benzinga Insights

Today, 6:41 AM

DuPont de Nemours's (NYSE:DD) short percent of float has fallen 21.05% since its last report. The company recently reported that it has 5.39 million shares sold short, which is 1.05% of all regular shares that are available for trading.

1 minute read

Analyst Ratings

What 8 Analyst Ratings Have To Say About DuPont de Nemours

By Benzinga Insights

Today, 6:41 AM

DuPont de Nemours (NYSE:DD) has observed the following analyst ratings within the last quarter:

1 minute read

Credit Suisse Maintains Outperform on DuPont de Nemours, Lowers Price Target to $86

By Benzinga Newsdesk

Today, 6:41 AM

Credit Suisse analyst John Walsh maintains DuPont de Nemours (NYSE:DD) with a Outperform and lowers the price target from $95 to $86.

1 minute read

Mizuho Maintains Buy on DuPont de Nemours, Lowers Price Target to $97

By Benzinga Newsdesk

Today, 6:41 AM

Mizuho analyst Christopher Parkinson maintains DuPont de Nemours (NYSE:DD) with a Buy and lowers the price target from $101 to $97.

2 minute read

20 Stocks Moving in Tuesday’s Pre-Market Session

By Lisa Levin

Today, 6:41 AM

Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for Nanocyn hospital-grade disinfectant in the U.S.

AIM